Black HFrEF Patients Fare Better With Empagliflozin
Empagliflozin trial data from patients with heart failure with reduced ejection fraction signal more benefit in Black compared with White patients.
United States Subodh Verma University Of Toronto American Heart Association Boehringer Ingelheim Linked Heterogeneity
Source: medscape.com